EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy

Yilin Chen, Shuaixuan Chen, Hang Zhang, Binbin Song, Yufen Xu

Cancer Immunology, Immunotherapy · 29.06.2026 · 75 (9)

DOI: 10.1007/s00262-026-04442-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 29.06.2026. Verfasst von Yilin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Lymphopenia, Neoplasms, Immunotherapy, Lymphocytes. Die Arbeit nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiaxing Science and Technology Plan Project, Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine-Oncology, National Clinical Key Specialty Construction Project-Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphopeniaNeoplasmsImmunotherapyLymphocytesMicrobiotaGastrointestinal MicrobiomeHumansAnimalsCombined Modality Therapy

Stichwörter der Autor:innen

Gut microbiotaImmune checkpoint inhibitors (ICIs)Microbiota–lymphocyte protective axis (MLPA)Radiation-induced lymphopenia (RIL)Radiotherapy (RT)

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.
  • The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China.
  • Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.
  • The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.

Förderung

  • Jiaxing Science and Technology Plan Project
  • Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine-Oncology
  • National Clinical Key Specialty Construction Project-Oncology
  • Jiaxing Key Laboratory of Oncology Radiotherapy
  • Jiaxing First Hospital Key Project
  • Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine—Oncology
  • National Clinical Key Specialty Construction Project—Oncology

Zitieren

APA

Chen, Y., Chen, S., Zhang, H., Song, B., & Xu, Y. (2026). The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. Cancer Immunology, Immunotherapy, 75(9). https://doi.org/10.1007/s00262-026-04442-8

Vancouver

Chen Y, Chen S, Zhang H, Song B, Xu Y. The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. Cancer Immunology, Immunotherapy. 2026;75(9). doi:10.1007/s00262-026-04442-8

BibTeX
@article{Chen2026,
  author = {Chen, Yilin and Chen, Shuaixuan and Zhang, Hang and Song, Binbin and Xu, Yufen},
  title = {The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {9},
  doi = {10.1007/s00262-026-04442-8}
}
Kostenlos starten →